Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.22.4
Consolidated Statements of Operations - USD ($)
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue $ 6,261 $ 4,696
Operating expenses:    
Cost of revenues 17,635 16,792
Selling, general and administrative expenses 1,102,916 1,263,104
Research and development expenses 161,453 234,618
Total costs and expenses 1,282,004 1,514,514
Loss from operations (1,275,743) (1,509,818)
Other expense:    
Interest expense (524,313) (40,329)
Total other expense (524,313) (40,329)
Net loss $ (1,800,056) $ (1,550,147)
Loss per share - basic and diluted    
Net loss per common share - basic and diluted (in dollars per share) $ (1.44) $ (1.31)
Weighted common shares - basic and diluted (in shares) 1,249,432 1,183,946